Skip to content
OpenCapital
Get started

Haemonetics HAE Enterprise value

Enterprise value at other companies

Abbott logo
AbbottABT
$205.65B-13.1%
TFX
TeleflexTFX
$7.74B-2.0%
Boston Scientific logo
Boston ScientificBSX
$141.04B-1.0%
Medtronic logo
MedtronicMDT
$131.22B-3.2%
LivaNova logo
LivaNovaLIVN
$3.28B+58.0%
ICU Medical logo
ICU MedicalICUI
$4.26B-10.6%

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.37B-18.0%
P/S2.5×-0.5×

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio3×+1.3×

Where this comes from

Calculated from Haemonetics’s reported figures.

$2.6Bmarket cap+$1.3Btotal debt−$245.4Mcash and equivalents=$3.65B

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's enterprise value?
Haemonetics (HAE) reported enterprise value of $3.65B in Q1 2026.
How has Haemonetics's enterprise value changed year-over-year?
Haemonetics's enterprise value decreased by 12.5% year-over-year, from $4.17B to $3.65B.
What is the long-term trend for Haemonetics's enterprise value?
Over 5 years (2021 to 2026), Haemonetics's enterprise value has grown at a -10.2% compound annual growth rate (CAGR), from $6.26B to $3.65B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.